Pharmanutra S.p.A. (BIT:PHN)
Italy · Delayed Price · Currency is EUR 82.50
+0.50 (0.61%)
Jul 28, 2026, 11:02 AM CET
Pharmanutra Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 102.25 | 136.25 | 118.32 | 101.96 | 83.39 | 68.84 | |
Revenue Growth | 17.16% | 15.15% | 16.05% | 22.27% | 21.15% | 17.31% |
Cost of Revenue | 4.95 | 8.08 | 3.55 | 7.85 | 6.76 | 4.24 |
Gross Profit | 97.3 | 128.17 | 114.77 | 94.12 | 76.63 | 64.6 |
Selling, General & Admin | 91.45 | 93.68 | 77.2 | 72.18 | 55.5 | 45.82 |
Depreciation & Amortization Expenses | 3.99 | 3.9 | 3.67 | 3.12 | 1.32 | 1.39 |
Other Operating Expenses | 1.73 | 1.68 | 2.29 | 0.85 | 0.71 | 0.64 |
Total Operating Expenses | 97.17 | 99.26 | 83.16 | 76.15 | 57.53 | 47.85 |
Operating Income | 31.49 | 30.31 | 27.37 | 23.36 | 23.04 | 18.69 |
Interest Expense | -1.18 | -1.09 | -1.62 | -1.01 | -0.15 | -0.04 |
Total Non-Operating Income (Expense) | -1.18 | -1.09 | -1.62 | -1.01 | -0.15 | -0.04 |
Pretax Income | 31.4 | 30.19 | 27.16 | 23.26 | 23.42 | 18.81 |
Provision for Income Taxes | 8.64 | 10.27 | 10.61 | 10.43 | 8.37 | 5.04 |
Net Income | 20.94 | 19.92 | 16.55 | 12.83 | 15.05 | 13.77 |
Minority Interest in Earnings | -0.08 | -0.09 | -0.06 | - | - | - |
Net Income to Common | 21.02 | 20 | 16.61 | 12.83 | 15.05 | 13.77 |
Net Income Growth | 28.08% | 20.44% | 29.43% | -14.73% | 9.27% | -2.14% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Change | -0.46% | -0.16% | -0.67% | -0.05% | -0.09% | - |
EPS (Basic) | 2.20 | 2.09 | 1.73 | 1.33 | 1.56 | 1.42 |
EPS (Diluted) | 2.20 | 2.09 | 1.73 | 1.33 | 1.56 | 1.42 |
EPS Growth | 28.66% | 20.81% | 30.08% | -14.74% | 9.86% | -2.07% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 16.02 | 16.43 | 16.17 | -1.16 | -8.69 | 15.43 |
Free Cash Flow Growth | -22.24% | 1.59% | - | - | - | 52.49% |
Free Cash Flow Per Share | 1.68 | 1.71 | 1.68 | -0.12 | -0.90 | 1.59 |
Dividends Per Share | 1.200 | 1.200 | 1.000 | 0.850 | 0.800 | 0.710 |
Dividend Growth | 20.00% | 20.00% | 17.65% | 6.25% | 12.68% | 5.97% |
Gross Margin | 95.16% | 94.07% | 97.00% | 92.30% | 91.89% | 93.85% |
Operating Margin | 30.80% | 22.25% | 23.13% | 22.91% | 27.63% | 27.15% |
Profit Margin | 20.48% | 14.62% | 13.99% | 12.58% | 18.04% | 20.01% |
FCF Margin | 15.66% | 12.06% | 13.67% | -1.14% | -10.42% | 22.41% |
EBITDA | 35.48 | 34.21 | 31.3 | 26.48 | 24.36 | 20.08 |
EBITDA Margin | 34.70% | 25.11% | 26.45% | 25.97% | 29.21% | 29.17% |
EBIT | 31.49 | 30.31 | 27.37 | 23.36 | 23.04 | 18.69 |
EBIT Margin | 30.80% | 22.25% | 23.13% | 22.91% | 27.63% | 27.15% |
Effective Tax Rate | 27.51% | 34.03% | 39.06% | 44.83% | 35.74% | 26.78% |